Skip to main content
. 2014 Dec 10;12:342. doi: 10.1186/s12967-014-0342-7

Table 3.

Analysis of melanoma recurrence according to MMP-23 expression in the entire cohort and the subset of patients who received immunotherapy after primary resection

MMP-23 composite score
Entire cohort a Immunotherapy after primary resection b
0 - 2 3 - 4 0 - 2 3 - 4
Recurrence
Yes 11 (59%) 42 (81%) 5 (46%) 23 (79%)
No 8 (41%) 10 (19%) 6 (54%) 6 (21%)
Total 19 (100%) 52 (100%) 11 (100%) 29 (100%)

aP = 0.067; bP = 0.056.